Mabqi
Discovers and develops therapeutic antibodies for biopharmaceutical partners and oncology treatment programs
Highlights
- New on EvolcAdded 2026-10-30
About Mabqi
Mabqi develops therapeutic antibodies and targeted therapies using its LiteMab Antibody Discovery Studio, which combines synthetic fully human antibody libraries with AI-powered phage and yeast display technologies. Its work includes antibody discovery and maturation, tumor-selective antibodies, antibody-drug conjugates, and multispecific antibodies.
The company develops proprietary oncology antibody candidates and offers its libraries and discovery expertise to the biopharmaceutical industry through partnerships and collaborative agreements. Some antibody candidates are available for licensing and partnerships.
Mabqi was established in 2017. Its headquarters and laboratories are in Montpellier, France, in the Euromedicine biopark; the registry lists Grabels as its HQ city. The company was founded by six scientists and serial entrepreneurs and has a team of 20–49 employees.
Product: Therapeutic antibody discovery and development, proprietary antibody candidates, and access to synthetic libraries and discovery expertise through partnerships.
Jobs at Mabqi
Leadership
- Sylvain Yon · CEOSource: company website
More biotech & pharma companies
Mabsilico
AI-based antibody candidate design for biotech and pharma companies, with candidates delivered in 21 daysNew on EvolcMetafora Biosystems
Develops single-cell metabolic testing and analysis for diagnostic and cell therapy applicationsNew on EvolcMexbrain
Develops dialysis-based medical devices to remove excess metals from the blood of patients with metal-related conditionsNew on EvolcMicrophyt
Microalgae-based ingredients for health, nutrition, well-being and beauty businessesNew on EvolcMimabs
Preclinical antibody and ADC discovery and development services for biotech, pharmaceutical and academic research partnersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- CookieYes
- Elementor
- Google Analytics 4
- Google reCAPTCHA
- PHP
- WordPress
- jQuery